Defensol D (multi Symptom Effervescent Tablets)
NDC Package 53145-320-06

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Defensol D (multi Symptom Effervescent Tablets) is • Do not take more than the recommended dose• Adults and children 12 years and over: take 2 tablets fully dissolved in 4oz. Marketed by Menper Distributors Inc., this product is identified by NDC 53145-320 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
53145-320-06
Package Description
6 POUCH in 1 BOX / 2 TABLET, EFFERVESCENT in 1 POUCH (53145-320-02)
Product Code
53145-320
11-Digit Billing Format
53145032006
RxNorm Crosswalk
  • RxCUI: 1536477 - acetaminophen 250 MG / chlorpheniramine maleate 2 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG Effervescent Oral Tablet
  • RxCUI: 1536477 - acetaminophen 250 MG / chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 10 MG / phenylephrine hydrochloride 5 MG Effervescent Oral Tablet
  • RxCUI: 1536477 - APAP 250 MG / Chlorpheniramine Maleate 2 MG / Dextromethorphan Hydrobromide 10 MG / Phenylephrine Hydrochloride 5 MG Effervescent Oral Tablet

Clinical Specifications

Proprietary Name
Defensol D (multi Symptom Effervescent Tablets)
Dosage Form
-
Usage Information
• Do not take more than the recommended dose• Adults and children 12 years and over: take 2 tablets fully dissolved in 4oz. of water every four hours. Do not exceed 8 tablets in 24 hours or as directed by a doctor• Children under 12 years: do not use

Regulatory & Marketing

Labeler Name
Menper Distributors Inc.
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
12-01-2015
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 53145-320-06 identifies a specific commercial package of 6 pouch in 1 box / 2 tablet, effervescent in 1 pouch (53145-320-02) of Defensol D (multi Symptom Effervescent Tablets), labeled by Menper Distributors Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Menper Distributors Inc. on December 01, 2015. The current certification is valid through December 31, 2017.

How is this Menper Distributors Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 53145032006. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
53145-320-06
11-Digit CMS (5-4-2)
53145-0320-06

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.